Classification
- Anatomical main groupMMusculo-skeletal system
- Therapeutic subgroupM05
- Pharmacological subgroupM05B
- Chemical subgroupM05BX
- Chemical substanceM05BX05Burosumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 6 registrations
- Crysvita 10 MG Solucion Inyectable10 mg · solución inyectable · Kyowa Kirin Holdings B.V.
- Crysvita 10 MG Solucion Inyectable en Jeringa Precargada10 mg · solucion para perfusion en jeringa precargada · Kyowa Kirin Holdings B.V.
- Crysvita 20 MG Solucion Inyectable20 mg · solución inyectable · Kyowa Kirin Holdings B.V.
- Crysvita 20 MG Solucion Inyectable en Jeringa Precargada20 mg · solucion para perfusion en jeringa precargada · Kyowa Kirin Holdings B.V.
Serbia
ALIMS · 6 registrations
At a glance
- ATC code
- M05BX05
- ATC group
- Musculo-skeletal system
- Registers
- 9
- Historical lists
- 2
- Registrations
- 34
- With their own page
- 27
- Companies
- 8
All medicines with Burosumab
Human medicines from every register that match Burosumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
34 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Crysvita | United States | 10MG/ML | injectable | Marketed | Kyowa Kirin |
| Crysvita | United States | 20MG/ML | Injection | Marketed | Kyowa Kirin, Inc. |
| Crysvita | United States | 30MG/ML | Injection | Marketed | Kyowa Kirin, Inc. |
| Crysvita | European Union | Authorised | Kyowa Kirin Holdings B.V. | ||
| Crysvita 10 MG Solucion Inyectable | Spain | 10 mg | solución inyectable | Marketed | Kyowa Kirin Holdings B.V. |
| Crysvita 10 MG Solucion Inyectable en Jeringa Precargada | Spain | 10 mg | solucion para perfusion en jeringa precargada | Marketed | Kyowa Kirin Holdings B.V. |
| Crysvita 20 MG Solucion Inyectable | Spain | 20 mg | solución inyectable | Marketed | Kyowa Kirin Holdings B.V. |
| Crysvita 20 MG Solucion Inyectable en Jeringa Precargada | Spain | 20 mg | solucion para perfusion en jeringa precargada | Marketed | Kyowa Kirin Holdings B.V. |
| Crysvita 30 MG Solucion Inyectable | Spain | 30 mg | solución inyectable | Marketed | Kyowa Kirin Holdings B.V. |
| Crysvita 30 MG Solucion Inyectable en Jeringa Precargada | Spain | 30 mg | solucion para perfusion en jeringa precargada | Marketed | Kyowa Kirin Holdings B.V. |
| CRYSVITA 10 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Kyowa Kirin Holdings B.V. | |
| CRYSVITA 20 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Kyowa Kirin Holdings B.V. | |
| CRYSVITA 30 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Kyowa Kirin Holdings B.V. | |
| Crysvita | Canada | 30 MG / ML | Solution | Marketed | Kyowa Kirin, INC. |
| Crysvita | Canada | 20 MG / ML | Solution | Marketed | Kyowa Kirin, INC. |
| Crysvita | Canada | 10 MG / ML | Solution | Marketed | Kyowa Kirin, INC. |
| Crysvita | Serbia | 30mg | rastvor za injekciju | Authorised | Amicus SRB D.O.O. |
| Crysvita | Serbia | 20mg | rastvor za injekciju | Authorised | Amicus SRB D.O.O. |
| Crysvita | Serbia | 10mg | rastvor za injekciju | Authorised | Amicus SRB D.O.O. |
| Crysvita | Brazil | Authorised | Ultragenyx Brasil Farmaceutica Ltda | ||
| Crysvita | Serbia | 30mg | rastvor za injekciju | Authorised | Amicus SRB D.O.O. |
| Crysvita | Serbia | 10mg | rastvor za injekciju | Authorised | Amicus SRB D.O.O. |
| Crysvita | Serbia | 20mg | rastvor za injekciju | Authorised | Amicus SRB D.O.O. |
| Crysvita® Solution for Injection 10 MG/ML | Singapore | 10 mg/ml | injection, solution | Authorised | DKSH Singapore Pte. LTD. |
| Crysvita® Solution for Injection 20 MG/ML | Singapore | 20 mg/ml | injection, solution | Authorised | DKSH Singapore Pte. LTD. |



